Telo Genomics Valuation
| TDSGF Stock | USD 0.09 0.02 34.29% |
Telo Genomics seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Telo Genomics Corp from inspecting the company fundamentals such as Return On Equity of -0.78, shares outstanding of 59.42 M, and Price To Book of 10.46 X as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Telo Genomics' price fluctuation is out of control at this time. Calculation of the real value of Telo Genomics Corp is based on 3 months time horizon. Increasing Telo Genomics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Telo otc stock is determined by what a typical buyer is willing to pay for full or partial control of Telo Genomics Corp. Since Telo Genomics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Telo OTC Stock. However, Telo Genomics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.094 | Real 0.0867 | Hype 0.09 | Naive 0.0736 |
The real value of Telo OTC Stock, also known as its intrinsic value, is the underlying worth of Telo Genomics Corp OTC Stock, which is reflected in its stock price. It is based on Telo Genomics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Telo Genomics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Telo Genomics Corp helps investors to forecast how Telo otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Telo Genomics more accurately as focusing exclusively on Telo Genomics' fundamentals will not take into account other important factors: Telo Genomics Total Value Analysis
Telo Genomics Corp is at this time forecasted to have takeover price of 13.73 M with market capitalization of 12.81 M, debt of 40 K, and cash on hands of 2.69 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Telo Genomics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
13.73 M | 12.81 M | 40 K | 2.69 M |
Telo Genomics Asset Utilization
One of the ways to look at asset utilization of Telo is to check how much profit was generated for every dollar of assets it reports. Telo Genomics Corp has a negative utilization of assets of -0.45 %, losing $0.00454 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Telo Genomics Corp shows how discouraging it operates for each dollar spent on its assets.Telo Genomics Ownership Allocation
Telo Genomics Corp shows a total of 59.42 Million outstanding shares. Telo Genomics Corp has 6.52 % of its outstanding shares held by insiders and 1.83 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Telo Genomics Profitability Analysis
Net Loss for the year was (2.11 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Telo Genomics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Telo Genomics and how it compares across the competition.
About Telo Genomics Valuation
The otc valuation mechanism determines Telo Genomics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Telo Genomics. We calculate exposure to Telo Genomics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Telo Genomics's related companies.Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada. TELO GENOMICS is traded on OTC Exchange in the United States.
8 Steps to conduct Telo Genomics' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Telo Genomics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Telo Genomics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Telo Genomics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Telo Genomics' revenue streams: Identify Telo Genomics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Telo Genomics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Telo Genomics' growth potential: Evaluate Telo Genomics' management, business model, and growth potential.
- Determine Telo Genomics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Telo Genomics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Telo Genomics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Telo Genomics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 59.4 M | |
| Retained Earnings | -22.3 M | |
| Shares Float | 53.6 M |
Complementary Tools for Telo OTC Stock analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |